Mohamed M. Khalifa

1.7k citations

49 papers · 1.2k indexed · h-index 23

Co-authors: Ibrahim H. Eissa Hazem A. Mahdy Eslam B. Elkaeed Ahmed M. Metwaly Khaled El‐Adl Rezk R. Ayyad Ahmed B. M. Mehany Ahmed A. Al‐Karmalawy
Topics: Synthesis and biological activity (7 papers)Angiogenesis and VEGF in Cancer (6 papers)Synthesis and Biological Evaluation (6 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Molecules The Journal of Pediatrics RSC Advances
Partner nations: Egypt Saudi Arabia United States

In The Last Decade

Mohamed M. Khalifa

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mohamed M. Khalifa

Since Specialization

Citations

This map shows the geographic impact of Mohamed M. Khalifa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed M. Khalifa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed M. Khalifa more than expected).

Fields of papers citing papers by Mohamed M. Khalifa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed M. Khalifa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed M. Khalifa. The network helps show where Mohamed M. Khalifa may publish in the future.

Co-authorship network of co-authors of Mohamed M. Khalifa

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed M. Khalifa. A scholar is included among the top collaborators of Mohamed M. Khalifa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed M. Khalifa. Mohamed M. Khalifa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches 2025 ·RSC Advances ·Hazem Elkady,(unknown),Mohamed M. Khalifa	0
2	Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities 2025 ·Archiv der Pharmazie ·Hazem Elkady,Walid E. Elgammal,Mohamed M. Khalifa,(unknown),Ahmed S. Ibrahim,(unknown),Bshra A. Alsfouk,Eslam B. Elkaeed,Ahmed M. Metwaly,Ibrahim H. Eissa	2
3	Discovery of potent anticancer tricarboxamide analogs linked to 1,2,3-triazole, promoting EGFR and VEGFR downregulation 2025 ·New Journal of Chemistry ·(unknown),(unknown),(unknown),(unknown),Mohamed M. Khalifa,Aeshah A. Awaji,Hany E. A. Ahmed,Nadjet Rezki	3
4	Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies 2024 ·Pharmaceuticals ·Ashraf K. El‐Damasy,(unknown),Ahmed A. Al‐Karmalawy,Radwan Alnajjar,Mohamed M. Khalifa,Eun‐Kyoung Bang,Gyochang Keum	3
5	Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers 2023 ·RSC Advances ·Abdulrahman M. Saleh,Hazem A. Mahdy,Mohamed Ayman El‐Zahabi,Ahmed B. M. Mehany,Mohamed M. Khalifa,Ibrahim H. Eissa	22
6	Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed Farrag El‐Behairy,(unknown),Mohamed M. Khalifa,Mohamed S. Nafie,Mohamed A. Saleh,Mohammed S. Abdel‐Maksoud,Tarfah Al‐Warhi,Wagdy M. Eldehna,Ahmed A. Al‐Karmalawy	19
7	Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists 2022 ·Pharmaceuticals ·Mohamed A. Abdelgawad,Khaled El‐Adl,Sanadelaslam S. A. El‐Hddad,(unknown),Nashwa M. Saleh,Mohamed M. Khalifa,(unknown),Mohamed Alswah,AbdElAziz A. Nayl,Mohammed M. Ghoneim,Nour E. A. Abd El‐Sattar	35
8	The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach 2022 ·Metabolites ·Eslam B. Elkaeed,Mohamed M. Khalifa,Bshra A. Alsfouk,Aisha A. Alsfouk,(unknown),Ibrahim H. Eissa,Ahmed M. Metwaly	10
9	Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies 2022 ·Molecules ·Eslam B. Elkaeed,Reda G. Yousef,Mohamed M. Khalifa,(unknown),Ahmed B. M. Mehany,(unknown),Bshra A. Alsfouk,Wagdy M. Eldehna,Ahmed M. Metwaly,Ibrahim H. Eissa,Mohamed Ayman El‐Zahabi	33
10	Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Reda G. Yousef,(unknown),Mohamed M. Khalifa,Wagdy M. Eldehna,(unknown),Ahmed B. M. Mehany,Eslam B. Elkaeed,Aisha A. Alsfouk,Ahmed M. Metwaly,Ibrahim H. Eissa	45
11	Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed S. Taghour,Hazem A. Mahdy,(unknown),(unknown),(unknown),Alaa Elwan,Mohammed A. Dahab,Eslam B. Elkaeed,Aisha A. Alsfouk,Mohamed M. Khalifa,Ibrahim H. Eissa,Hazem Elkady	43
12	Design, Synthesis, In‐Vivo Anti‐Diabetic Activity, In‐Vitro α‐Glucosidase Inhibitory Activity and Molecular Docking Studies of Some Quinazolinone Derivatives 2022 ·ChemistrySelect ·(unknown),Helmy Sakr,Rezk R. Ayyad,Mohamed M. Khalifa	6
13	Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation 2021 ·Oxidative Medicine and Cellular Longevity ·Feng Ran,Wendong Li,Yi Qin,Tong Yu,(unknown),Min Zhou,Cheng Liu,Tong Qiao,Xiaoqiang Li,Reda G. Yousef,Ibrahim H. Eissa,Mohamed M. Khalifa	31
14	In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10 2021 ·Molecules ·Ibrahim H. Eissa,Mohamed M. Khalifa,Eslam B. Elkaeed,E. S. E. Hafez,Aisha A. Alsfouk,Ahmed M. Metwaly	52
15	Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking 2021 ·Archiv der Pharmazie ·Nashwa M. Saleh,Adel A.‐H. Abdel‐Rahman,(unknown),Mohamed M. Khalifa,Khaled El‐Adl	42
16	Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors 2021 ·Archiv der Pharmazie ·Helmy Sakr,Rezk R. Ayyad,(unknown),Mohamed M. Khalifa,Hazem A. Mahdy	11
17	Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors 2020 ·Bioorganic & Medicinal Chemistry ·Khaled El‐Adl,Abdel‐Ghany A. El‐Helby,Rezk R. Ayyad,Hazem A. Mahdy,Mohamed M. Khalifa,(unknown),Ahmed B. M. Mehany,Ahmed M. Metwaly,Mostafa A. Elhendawy,Mohamed M. Radwan,Mahmoud A. ElSohly,Ibrahim H. Eissa	85
18	Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation 2020 ·Bioorganic Chemistry ·Ibrahim H. Eissa,Abdel‐Ghany A. El‐Helby,Hazem A. Mahdy,Mohamed M. Khalifa,(unknown),Ahmed B. M. Mehany,Ahmed M. Metwaly,Mostafa A. Elhendawy,Aly F. Mohamed,Mahmoud A. ElSohly,Khaled El‐Adl	80
19	Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature 2017 ·European Journal of Medical Genetics ·(unknown),(unknown),Mohamed M. Khalifa	13
20	Hutchinson‐Gilford progeria syndrome: report of a Libyan family and evidence of autosomal recessive inheritance 1989 ·Clinical Genetics ·Mohamed M. Khalifa	24

About Mohamed M. Khalifa

Mohamed M. Khalifa is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Synthesis and Biological Evaluation (6 papers). The work is most often cited by research in Toxicology (159 citations), Organic Chemistry (537 citations) and Molecular Biology (612 citations). Mohamed M. Khalifa has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Ibrahim H. Eissa, Hazem A. Mahdy, Eslam B. Elkaeed, Ahmed M. Metwaly, Khaled El‐Adl, Rezk R. Ayyad, Ahmed B. M. Mehany, Ahmed A. Al‐Karmalawy, Alessandra M.V. Duncan and Helmy Sakr. Their work appears in journals such as Molecules, The Journal of Pediatrics and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact